Closing Bell

Biopharm Closing Bell: 7.1.08

Gainers (% price change)		Last Trade	Change	Mkt Cap
NxStage Medical, Inc.	NXTM	4.42	+0.58 (15.10%)	162.63M
Myriad Genetics, Inc.	MYGN	51.39	+5.87 (12.90%)	2.29B
The Aristotle Corporation	ARTL	8.38	+0.92 (12.33%)	150.52M
DepoMed, Inc.	DEPO	3.50	+0.29 (9.03%)	168.09M
Celgene Corporation	CELG	69.26	+5.39 (8.44%)	30.19B
Losers (% price change)
Senomyx Inc.	SNMX	4.23	-0.70 (-14.20%)	129.39M
Protherics PLC (ADR)	PTIL	6.50	-0.74 (-10.22%)	220.49M
Marshall Edwards, Inc.	MSHL	2.31	-0.26 (-10.12%)	159.05M
Optimer Pharmaceuticals,	OPTR	7.36	-0.75 (-9.25%)	205.53M
MiddleBrook	MBRK	3.07	-0.31 (-9.17%)	171.94M
Most Actives (dollar volume)
Celgene Corporation	CELG	69.26	+5.39 (8.44%)	30.19B
Johnson & Johnson	JNJ	64.69	+0.35 (0.54%)	182.31B
Pfizer Inc.	PFE	17.73	+0.26 (1.49%)	119.95B
Merck & Co., Inc.	MRK	38.36	+0.67 (1.78%)	82.34B
Amgen, Inc.	AMGN	48.64	+1.48 (3.14%)	52.95B

Theoretically Related Posts

• June 30, 2008 -- Biopharm Closing Bell: 6.30.08 (0)
• June 30, 2008 -- Myriad Cancels Flurizan Development (1)
• May 23, 2008 -- Memorial Weekend Financing (0)
• May 22, 2008 -- Failed Drug in Alzheimers and Prostate Cancer Gets Licensed in Europe (1)
• March 27, 2008 -- Top Biopharma Deals Q1 ‘08 (0)

© 2008 Pharmababble.